Tag: neurological injury

RegeneRX receives Canadian patent for treating neurological injury and damage

RegeneRx Biopharmaceuticals has announced that the Canadian Patent Office has issued a Notice of Allowance for Thymosin beta 4 (Tβ4) for use in the treatment...